Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab

NCT04014374 · clinicaltrials.gov ↗
RECRUITING
Status
150
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Kyowa Kirin, Inc.